Real World Data (RWD) Global Market Report 2026

Real-world data (RWD) refers to health-related information collected outside traditional clinical trials from sources such as electronic health records (EHRs), insurance claims, patient registries, wearable devices, and patient-reported outcomes. It captures healthcare delivery and patient experiences in real-life settings. The primary goal of RWD is to provide insights into treatment performance across broader, more diverse populations under real-world conditions. It supports regulatory decisions, drug development, post-market surveillance, and personalized medicine by complementing data from controlled clinical trials.

The main components of real-world data (RWD) include services and datasets. Services encompass professional solutions that assist in data collection, analysis, integration, and interpretation within healthcare and research, helping transform raw data into actionable insights for decision-making and development. RWD is applied in various areas such as drug development and approvals, market access, reimbursement and coverage decisions, post-market surveillance, clinical research, and more. It serves a broad range of end users, including pharmaceutical and medical device companies, healthcare payers, healthcare providers, government agencies, and others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Tariffs are impacting the real world data market by increasing costs of imported data infrastructure hardware, cloud computing equipment, cybersecurity solutions, and advanced analytics platforms used for large-scale healthcare data processing. Pharmaceutical and healthcare analytics providers in North America and Europe are most affected due to reliance on global IT supply chains, while Asia-Pacific faces cost pressure on data platform expansion. These tariffs are increasing operational expenses and slowing technology upgrades. However, they are also encouraging localized data infrastructure investments, regional cloud partnerships, and development of cost-efficient analytics solutions.

The real world data (rwd) market research report is one of a series of new reports from The Business Research Company that provides real world data (rwd) market statistics, including real world data (rwd) industry global market size, regional shares, competitors with a real world data (rwd) market share, detailed real world data (rwd) market segments, market trends and opportunities, and any further data you may need to thrive in the real world data (rwd) industry. This real world data (rwd) market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The real world data (rwd) market size has grown rapidly in recent years. It will grow from $2.01 billion in 2025 to $2.34 billion in 2026 at a compound annual growth rate (CAGR) of 16.1%. The growth in the historic period can be attributed to growth of electronic health record adoption, expansion of healthcare digitization initiatives, rising demand for post-market drug surveillance, increasing availability of claims and registry data, early use of observational studies in healthcare research.

The real world data (rwd) market size is expected to see rapid growth in the next few years. It will grow to $4.21 billion in 2030 at a compound annual growth rate (CAGR) of 15.8%. The growth in the forecast period can be attributed to increasing regulatory acceptance of real-world evidence, rising focus on personalized medicine, expansion of AI-driven healthcare analytics, growing investments in digital health infrastructure, increasing use of rwd in value-based care models. Major trends in the forecast period include increasing adoption of real-world evidence in drug approvals, rising integration of multi-source healthcare datasets, growing use of wearable and patient-generated data, expansion of advanced data analytics platforms, enhanced focus on data standardization and interoperability.

The rising adoption of electronic health records is expected to drive the expansion of the real-world data (RWD) market in the coming years. Electronic health records are digital versions of patients' medical charts that store and manage comprehensive health information to enhance care coordination and support clinical decision-making. This growing adoption is mainly driven by the need to improve patient care and safety, as electronic health records allow accurate, real-time access to patient data, minimize medical errors, and strengthen clinical decision-making. Real-world data complements electronic health records by offering insights into patient outcomes and the effectiveness of treatments in routine clinical practice, enabling more personalized and evidence-based care. For example, in November 2023, according to NHS England, a UK-based government health authority, 90% of NHS hospital trusts had implemented an Electronic Patient Record (EPR) system, reaching the national adoption target ahead of schedule. As a result, the increasing use of electronic health records is supporting the growth of the real-world data market.

Leading companies in the real-world data (RWD) sector are prioritizing the development of innovative solutions, such as integrated analysis-ready datasets, to simplify evidence generation and speed up clinical decision-making. An integrated analysis-ready dataset is a cleaned, standardized, and combined compilation of data from multiple sources that can be used for analysis immediately, without the need for further preprocessing. For example, in January 2025, Carelon Research, Inc., a US-based healthcare research company, introduced Carelon Real World Data, a comprehensive, analysis-ready dataset aimed at enhancing healthcare evidence generation. This dataset provides a complete, analysis-ready resource that merges closed claims with electronic health records, offering detailed insights on patients, providers, and payers. It also incorporates enriched information on oncology, lab results, race and ethnicity, and social determinants of health. Developed based on decades of research, the dataset is customized to address specific research needs and supports evidence generation across all therapeutic areas for life sciences teams.

In December 2023, Finland-based BC Platforms, a company specializing in building data networks for the life sciences sector, acquired Medexprim for an undisclosed amount. Through this acquisition, BC Platforms aims to expand its real-world data capabilities, particularly by integrating Medexprim's clinical imaging expertise, thereby enhancing their ability to deliver comprehensive, multi-modal healthcare data solutions for research and innovation. Medexprim is a France-based software company that provides real-world data and real-world evidence solutions.

Major companies operating in the real world data (rwd) market are Oracle Corporation, IQVIA Holdings Inc., ICON Public Limited Company, Syneos Health Inc., Parexel International Corporation, Revvity Inc., SAS Institute Inc., Datavant Inc., Palantir Technologies Inc., Tempus Labs Inc., Clarivate Plc, Flatiron Health Inc., Tempus Labs Inc., Clinigen Group plc, Komodo Health Inc., Aetion Inc., TriNetX LLC, Clarify Health Solutions Inc., Verana Health Inc., Evidation Health Inc., OM1 Inc., HealthVerity Inc., Pulse Infoframe Inc.

North America was the largest region in the real world data (RWD) market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the real world data (rwd) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the real world data (rwd) market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The real-world data (RWD) market includes revenues earned by entities by providing services, such as data collection services, data aggregation and integration, data analytics and insights, data licensing and subscription, and real-time monitoring services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Real World Data (RWD) Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses real world data (rwd) market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for real world data (rwd) ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The real world data (rwd) market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Component: Services; Datasets
• 2) By Application: Drug Development And Approvals; Market Access And Reimbursement And Coverage Decisions; Post-Market Surveillance; Clinical Research; Other Applications
• 3) By End User: Pharmaceutical And Medical Device Companies; Healthcare Payers; Healthcare Providers; Government Agencies; Other End Users
• Subsegments:
• 1) By Services: Data Collection Services; Data Integration And Management Services; Data Analytics And Visualization Services; Data Validation And Standardization Services; Regulatory Compliance And Consulting Services
• 2) By Datasets: Claims Data; Pharmacy Data; Electronic Health Records; Patient-Generated Health Data; Laboratory And Diagnostic Data; Genomic Data
• Companies Mentioned: Oracle Corporation; IQVIA Holdings Inc.; ICON Public Limited Company; Syneos Health Inc.; Parexel International Corporation; Revvity Inc.; SAS Institute Inc.; Datavant Inc.; Palantir Technologies Inc.; Tempus Labs Inc.; Clarivate PLC; Flatiron Health Inc.; Tempus Labs Inc.; Clinigen Group PLC; Komodo Health Inc.; Aetion Inc.; TriNetX LLC; Clarify Health Solutions Inc.; Verana Health Inc.; Evidation Health Inc.; OM1 Inc.; HealthVerity Inc.; Pulse Infoframe Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.